1 Schaale K, "Wnt6 is expressed in granulomatous lesions of Mycobacterium tuberculosis-infected mice and is involved in macrophage differentiation and proliferation" 191 : 5182-5195, 2013
2 Kamada N, "Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis" 118 : 2269-2280, 2008
3 Hansen G, "The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation" 134 : 496-507, 2008
4 Neurath MF, "The role of Th1/Th2 polarization in mucosal immunity" 8 : 567-573, 2002
5 Mantovani A, "The chemokine system in diverse forms of macrophage activation and polarization" 25 : 677-686, 2004
6 Martinez FO, "The M1 and M2 paradigm of macrophage activation: time for reassessment" 6 : 13-, 2014
7 Qualls JE, "Suppression of experimental colitis by intestinal mononuclear phagocytes" 80 : 802-815, 2006
8 Turner K, "Significance of the epithelioid granuloma in biopsies of Crohn's colitis" 20 : 2271-2275, 2014
9 Maloy KJ, "Regulatory T cells in the control of immune pathology" 2 : 816-822, 2001
10 Buechler C, "Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli" 67 : 97-103, 2000
1 Schaale K, "Wnt6 is expressed in granulomatous lesions of Mycobacterium tuberculosis-infected mice and is involved in macrophage differentiation and proliferation" 191 : 5182-5195, 2013
2 Kamada N, "Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis" 118 : 2269-2280, 2008
3 Hansen G, "The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation" 134 : 496-507, 2008
4 Neurath MF, "The role of Th1/Th2 polarization in mucosal immunity" 8 : 567-573, 2002
5 Mantovani A, "The chemokine system in diverse forms of macrophage activation and polarization" 25 : 677-686, 2004
6 Martinez FO, "The M1 and M2 paradigm of macrophage activation: time for reassessment" 6 : 13-, 2014
7 Qualls JE, "Suppression of experimental colitis by intestinal mononuclear phagocytes" 80 : 802-815, 2006
8 Turner K, "Significance of the epithelioid granuloma in biopsies of Crohn's colitis" 20 : 2271-2275, 2014
9 Maloy KJ, "Regulatory T cells in the control of immune pathology" 2 : 816-822, 2001
10 Buechler C, "Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli" 67 : 97-103, 2000
11 Jablonski KA, "Novel markers to delineate murine M1 and M2 macrophages" 10 : e0145342-, 2015
12 Tobal K, "Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia" 4 : 486-489, 1990
13 Lissner D, "Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD" 21 : 1297-1305, 2015
14 Lugo-Villarino G, "Macrophage polarization: convergence point targeted by mycobacterium tuberculosis and HIV" 2 : 43-, 2011
15 Barros MH, "Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages" 8 : e80908-, 2013
16 Magnusson MK, "Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation" 9 : 171-182, 2016
17 Mills CD, "M-1/M-2 macrophages and the Th1/Th2 paradigm" 164 : 6166-6173, 2000
18 Doyle AG, "Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma" 24 : 1441-1445, 1994
19 Stein M, "Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation" 176 : 287-292, 1992
20 Ahuja V, "Inflammatory bowel disease: the Indian augury" 31 : 294-296, 2012
21 Ogino T, "Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease" 145 : 1380-1391, 2013
22 Matta SK, "Hypoxia and classical activation limits Mycobacterium tuberculosis survival by Akt-dependent glycolytic shift in macrophages" 2 : 16022-, 2016
23 Sulahian TH, "Human monocytes express CD163, which is upregulated by IL-10 and identical to p155" 12 : 1312-1321, 2000
24 Koboziev I, "Gut-associated lymphoid tissue, T cell trafficking, and chronic intestinal inflammation" 1207 (1207): E86-E93, 2010
25 Freeman HJ, "Granuloma-positive Crohn's disease" 21 : 583-587, 2007
26 Stange EF, "European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis" 55 (55): i1-i15, 2006
27 Pratap Mouli V, "Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn's disease" 45 : 27-36, 2017
28 Kuhl AA, "Diversity of intestinal macrophages in inflammatory bowel diseases" 6 : 613-, 2015
29 de Jong YP, "Development of chronic colitis is dependent on the cytokine MIF" 2 : 1061-1066, 2001
30 Moser M, "Dendritic cell regulation of TH1-TH2 development" 1 : 199-205, 2000
31 Lacey DC, "Defining GM-CSFand macrophage-CSF-dependent macrophage responses by in vitro models" 188 : 5752-5765, 2012
32 Isidro RA, "Colonic macrophage polarization in homeostasis, inflammation, and cancer" 311 : G59-G73, 2016
33 Makharia GK, "Clinical, endoscopic, and histological differentiations between Crohn's disease and intestinal tuberculosis" 105 : 642-651, 2010
34 Mackaness GB, "Cellular resistance to infection" 116 : 381-406, 1962
35 Tamoutounour S, "CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis" 42 : 3150-3166, 2012
36 Thiesen S, "CD14(hi) HLA-DR(dim) macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's disease" 95 : 531-541, 2014
37 Paustian F, "Bockus gastroenterology" Saunders 3304-, 1995
38 Blumberg RS, "Animal models of mucosal inflammation and their relation to human inflammatory bowel disease" 11 : 648-656, 1999
39 Cossarizza A, "A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1)" 197 : 40-45, 1993